Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Safety and immunogenicity of Salmonella typhi Ty21a liquid formulation vaccine in 4- to 6-year-old Thai children.

× No keyword cloud information.

12 in total

Review 1. Live attenuated vaccines for invasive Salmonella infections.

Authors: Sharon M Tennant; Myron M Levine
Journal: Vaccine Date: 2015-04-19 Impact factor: 3.641

2. Randomized, double-blind placebo-controlled trial to evaluate the safety and immunogenicity of combined Salmonella typhi Ty21a and Vibrio cholerae CVD 103-HgR live oral vaccines.

Authors: H Kollaritsch; E Furer; C Herzog; G Wiedermann; J U Que; S J Cryz
Journal: Infect Immun Date: 1996-04 Impact factor: 3.441

3. Mucosal priming of newborn mice with S. Typhi Ty21a expressing anthrax protective antigen (PA) followed by parenteral PA-boost induces B and T cell-mediated immunity that protects against infection bypassing maternal antibodies.

Authors: Karina Ramirez; Yanina Ditamo; James E Galen; Les W J Baillie; Marcela F Pasetti
Journal: Vaccine Date: 2010-07-07 Impact factor: 3.641

4. Engineering and preclinical evaluation of attenuated nontyphoidal Salmonella strains serving as live oral vaccines and as reagent strains.

Authors: Sharon M Tennant; Jin-Yuan Wang; James E Galen; Raphael Simon; Marcela F Pasetti; Orit Gat; Myron M Levine
Journal: Infect Immun Date: 2011-08-01 Impact factor: 3.441

5. Antibodies in action: role of human opsonins in killing Salmonella enterica serovar Typhi.

Authors: Janet C Lindow; Kelly A Fimlaid; Janice Y Bunn; Beth D Kirkpatrick
Journal: Infect Immun Date: 2011-05-31 Impact factor: 3.441

6. Safety and immunogenicity of a live oral bivalent typhoid fever (Salmonella typhi Ty21a)-cholera (Vibrio cholerae CVD 103-HgR) vaccine in healthy adults.

Authors: S J Cryz; J U Que; M M Levine; G Wiedermann; H Kollaritsch
Journal: Infect Immun Date: 1995-04 Impact factor: 3.441

Safety and immunogenicity of Salmonella typhi Ty21a liquid formulation vaccine in 4- to 6-year-old Thai children.

Review 1. Live attenuated vaccines for invasive Salmonella infections.

2. Randomized, double-blind placebo-controlled trial to evaluate the safety and immunogenicity of combined Salmonella typhi Ty21a and Vibrio cholerae CVD 103-HgR live oral vaccines.

3. Mucosal priming of newborn mice with S. Typhi Ty21a expressing anthrax protective antigen (PA) followed by parenteral PA-boost induces B and T cell-mediated immunity that protects against infection bypassing maternal antibodies.

4. Engineering and preclinical evaluation of attenuated nontyphoidal Salmonella strains serving as live oral vaccines and as reagent strains.

5. Antibodies in action: role of human opsonins in killing Salmonella enterica serovar Typhi.

6. Safety and immunogenicity of a live oral bivalent typhoid fever (Salmonella typhi Ty21a)-cholera (Vibrio cholerae CVD 103-HgR) vaccine in healthy adults.

Review 7. Vaccination against typhoid fever: present status.

Review 8. Vaccines for preventing typhoid fever.

Review 9. Live-Attenuated Bacterial Vectors: Tools for Vaccine and Therapeutic Agent Delivery.

10. Longevity of duodenal and peripheral T-cell and humoral responses to live-attenuated Salmonella Typhi strain Ty21a.